Lithium attenuated the depressant and anxiogenic effect of juvenile social stress through mitigating the negative impact of interlukin-1β and nitric oxide on hypothalamic-pituitary-adrenal axis function

Neuroscience

Volumn 315, Issue , 2016, Pages 271-285

  Haj Mirzaian, A ^a,b   Amiri, S ^a,b   Kordjazy, N ^a,b   Momeny, M ^a,b   Razmi, A ^c   Rahimi Balaei, M ^d   Amini Khoei, H ^a,b   Marzban, H ^d   Mehr, S E ^a,b   Dehpour, A R ^a,b   Ghaffari, S H ^e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c AVICENNA RESEARCH INSTITUTE   (Iran)

^d UNIVERSITY OF MANITOBA   (Canada)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Depressive like behaviors; Hypothalamic pituitary adrenal axis; Interlukine 1 ; Juvenile social isolation stress; Lithium; Nitric oxide

Indexed keywords

AMINOGUANIDINE; INTERLEUKIN 1BETA; LITHIUM; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CORTICOSTERONE; IL1B PROTEIN, MOUSE; LITHIUM DERIVATIVE; NITRITE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ANXIETY; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DRUG EFFICACY; DRUG RESPONSE; FORCED SWIM TEST; GENE; GENE EXPRESSION; HIPPOCAMPUS; HPRT1 GENE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; SOCIAL STRESS; TRANQUILIZING ACTIVITY; ANIMAL; ANXIETY DISORDERS; BLOOD; DEPRESSIVE DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HYPOPHYSIS ADRENAL SYSTEM; MENTAL STRESS; METABOLISM; MOTOR ACTIVITY; PATHOPHYSIOLOGY; SOCIAL ISOLATION;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; CORTICOSTERONE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERLEUKIN-1BETA; LITHIUM COMPOUNDS; MALE; MICE; MOTOR ACTIVITY; NITRIC OXIDE; NITRITES; PITUITARY-ADRENAL SYSTEM; SOCIAL ISOLATION; STRESS, PSYCHOLOGICAL;

EID: 84952683638     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.12.024     Document Type: Article

References (79)

1. Albayrak A., Halici Z., Polat B., Karakus E., Cadirci E., Bayir Y., Kunak S., Karcioglu S.S., Yigit S., Unal D. Protective effects of lithium: a new look at an old drug with potential antioxidative and anti-inflammatory effects in an animal model of sepsis. Int Immunopharmacol 2013, 16:35-40.
2. Amiri S., Amini-Khoei H., Haj-Mirzaian A., Rahimi-Balaei M., Naserzadeh P., Dehpour A., Mehr S.E., Hosseini M.-J. Tropisetron attenuated the anxiogenic effects of social isolation by modulating nitrergic system and mitochondrial function. Biochim Biophys Acta 2015, 1850:2464-2475.
3. Amiri S., Haj-Mirzaian A., Rahimi-Balaei M., Razmi A., Kordjazy N., Shirzadian A., Mehr S.E., Sianati H., Dehpour A.R. Co-occurrence of anxiety and depressive-like behaviors following adolescent social isolation in male mice; possible role of nitrergic system. Physiol Behav 2015, 145:38-44.
4. Andersen S.L., Teicher M.H. Stress, sensitive periods and maturational events in adolescent depression. Trends Neurosci 2008, 31:183-191.
5. Austin M., Souza F., Goodwin G. Lithium augmentation in antidepressant-resistant patients. A quantitative analysis. Br J Psychiatry 1991, 159:510-514.
6. Berry A., Bellisario V., Capoccia S., Tirassa P., Calza A., Alleva E., Cirulli F. Social deprivation stress is a triggering factor for the emergence of anxiety-and depression-like behaviours and leads to reduced brain BDNF levels in C57BL/6J mice. Psychoneuroendocrinology 2012, 37:762-772.
7. Beurel E., Jope R.S. Inflammation and lithium: clues to mechanisms contributing to suicide-linked traits. Transl Psychiatry 2014, 4:488.
8. Boku S., Nakagawa S., Masuda T., Nishikawa H., Kato A., Kitaichi Y., Inoue T., Koyama T. Glucocorticoids and lithium reciprocally regulate the proliferation of adult dentate gyrus-derived neural precursor cells through GSK-3β and β-catenin/TCF pathway. Neuropsychopharmacology 2009, 34:805-815.
9. Bschor T. Lithium in the treatment of major depressive disorder. Drugs 2014, 74:855-862.
10. Bschor T., Adli M., Baethge C., Eichmann U., Ising M., Uhr M., Modell S., Künzel H., Müller-Oerlinghausen B., Bauer M. Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression. Neuropsychopharmacology 2002, 27:470-478.
11. Chang C.H., Hsiao Y.H., Chen Y.W., Yu Y.J., Gean P.W. Social isolation-induced increase in NMDA receptors in the hippocampus exacerbates emotional dysregulation in mice. Hippocampus 2015, 25:474-485.
12. Chen H.-J.C., Spiers J.G., Sernia C., Lavidis N.A. Response of the nitrergic system to activation of the neuroendocrine stress axis. Front Neurosci 2015, 9(3):1-7.
13. Chiu C.-T., Scheuing L., Liu G., Liao H.-M., Linares G.R., Lin D., Chuang D.-M. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress. Int J Neuropsychopharmacol 2015, 8(6):1-13.
14. Cockroft K.M., Meistrell M., Zimmerman G.A., Risucci D., Bloom O., Cerami A., Tracey K.J. Cerebroprotective effects of aminoguanidine in a rodent model of stroke. Stroke 1996, 27:1393-1398.
15. Cryan J.F., Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 2005, 4:775-790.
16. Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am 2009, 29:247-264.
17. David D.J., Samuels B.A., Rainer Q., Wang J.-W., Marsteller D., Mendez I., Drew M., Craig D.A., Guiard B.P., Guilloux J.-P. Neurogenesis-dependent and-independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 2009, 62:479-493.
18. Detanico B.C., Piato Â.L., Freitas J.J., Lhullier F.L., Hidalgo M.P., Caumo W., Elisabetsky E. Antidepressant-like effects of melatonin in the mouse chronic mild stress model. Eur J Pharmacol 2009, 607:121-125.
19. Ding J., Li Q.Y., Wang X., Sun C.H., Lu C.Z., Xiao B.G. Fasudil protects hippocampal neurons against hypoxia-reoxygenation injury by suppressing microglial inflammatory responses in mice. J Neurochem 2010, 114:1619-1629.
20. Doherty G.H. Nitric oxide in neurodegeneration: potential benefits of non-steroidal anti-inflammatories. Neurosci Bull 2011, 27:366-382.
21. Droste S.K., de Groote L., Atkinson H.C., Lightman S.L., Reul J.M., Linthorst A.C. Corticosterone levels in the brain show a distinct ultradian rhythm but a delayed response to forced swim stress. Endocrinology 2008, 149:3244-3253.
22. Evans J., Sun Y., McGregor A., Connor B. Allopregnanolone regulates neurogenesis and depressive/anxiety-like behaviour in a social isolation rodent model of chronic stress. Neuropharmacology 2012, 63:1315-1326.
23. Fone K.C.F., Porkess M.V. Behavioural and neurochemical effects of post-weaning social isolation in rodents-relevance to developmental neuropsychiatric disorders. Neurosci Biobehav Rev 2008, 32:1087-1102.
24. Frank M.G., Hershman S.A., Weber M.D., Watkins L.R., Maier S.F. Chronic exposure to exogenous glucocorticoids primes microglia to pro-inflammatory stimuli and induces NLRP3 mRNA in the hippocampus. Psychoneuroendocrinology 2014, 40:191-200.
25. Gadek-Michalska A., Bugajski J. Nitric oxide mediates the interleukin-1beta-and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress. J Physiol Pharmacol 2005, 56:491-503.
26. Gadek-Michalska A., Spyrka J., Rachwalska P., Tadeusz J., Bugajski J. Influence of chronic stress on brain corticosteroid receptors and HPA axis activity. Pharmacol Rep 2013, 65:1163-1175.
27. Gadek-Michalska A., Tadeusz J., Rachwalska P., Bugajski J. Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems. Pharmacol Rep 2013, 65:1655-1662.
28. Gadek-Michalska A., Tadeusz J., Rachwalska P., Spyrka J., Bugajski J. Brain nitric oxide synthases in the interleukin-1β-induced activation of hypothalamic-pituitary-adrenal axis. Pharmacol Rep 2012, 64:1455-1465.
29. Ghasemi M., Dehpour A.R. The NMDA receptor/nitric oxide pathway: a target for the therapeutic and toxic effects of lithium. Trends Pharmacol Sci 2011, 32:420-434.
30. Ghasemi M., Sadeghipour H., Mosleh A., Sadeghipour H.R., Mani A.R., Dehpour A.R. Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test. Eur Neuropsychopharmacol 2008, 18:323-332.
31. Ghasemi M., Sadeghipour H., Poorheidari G., Dehpour A.R. A role for nitrergic system in the antidepressant-like effects of chronic lithium treatment in the mouse forced swimming test. Behav Brain Res 2009, 200:76-82.
32. Goshen I., Kreisel T., Ben-Menachem-Zidon O., Licht T., Weidenfeld J., Ben-Hur T., Yirmiya R. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry 2008, 13:717-728.
33. Goshen I., Yirmiya R. Interleukin-1 (IL-1): a central regulator of stress responses. Front Neuroendocrinol 2009, 30:30-45.
34. Gould T.D., O'Donnell K.C., Dow E.R., Du J., Chen G., Manji H.K. Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test. Neuropharmacology 2008, 54:577-587.
35. Gray J.D., McEwen B.S. Lithium's role in neural plasticity and its implications for mood disorders. Acta Psychiatr Scand 2013, 128:347-361.
36. Grippo A.J., Gerena D., Huang J., Kumar N., Shah M., Ughreja R., Carter C.S. Social isolation induces behavioral and neuroendocrine disturbances relevant to depression in female and male prairie voles. Psychoneuroendocrinology 2007, 32:966-980.
37. Grippo A.J., Wu K.D., Hassan I., Carter C.S. Social isolation in prairie voles induces behaviors relevant to negative affect: toward the development of a rodent model focused on co-occurring depression and anxiety. Depress Anxiety 2008, 25:17-26.
38. Gyulai L., Wicklund S.W., Greenstein R., Bauer M.S., Ciccione P., Whybrow P.C., Zimmerman J., Kovachich G., Alves W. Measurement of tissue lithium concentration by lithium magnetic resonance spectroscopy in patients with bipolar disorder. Biol Psychiatry 1991, 29:1161-1170.
39. Haj-Mirzaian A., Amiri S., Kordjazy N., Rahimi-Balaei M., Haj-Mirzaian A., Marzban H., Aminzadeh A., Dehpour A.R., Mehr S.E. Blockade of NMDA receptors reverses the depressant, but not anxiogenic effect of adolescence social isolation in mice. Eur J Pharmacol 2015, 750:160-166.
40. Hall F.S., Huang S., Fong G.F., Pert A. The effects of social isolation on the forced swim test in Fawn hooded and Wistar rats. J Neurosci Methods 1998, 79:47-51.
41. Harkin A.J., Bruce K.H., Craft B., Paul I.A. Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test. Eur J Pharmacol 1999, 372:207-213.
42. Harvey B.H., Oosthuizen F., Brand L., Wegener G., Stein D.J. Stress-restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus. Psychopharmacology 2004, 175:494-502.
43. Hawkley L.C., Cole S.W., Capitanio J.P., Norman G.J., Cacioppo J.T. Effects of social isolation on glucocorticoid regulation in social mammals. Horm Behav 2012, 62:314-323.
44. Joca S.R.L., Guimarães F.S. Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects. Psychopharmacology 2006, 185:298-305.
45. Kordjazy N., Haj-Mirzaian A., Amiri S., Ostadhadi S., Kordjazy M., Sharifzadeh M., Dehpour A.R. Elevated level of nitric oxide mediates the anti-depressant effect of rubidium chloride in mice. Eur J Pharmacol 2015, 762:411-418.
46. Kovacsics C.E., Gould T.D. Shock-induced aggression in mice is modified by lithium. Pharmacol Biochem Behav 2010, 94:380-386.
47. Krass M., Wegener G., Vasar E., Volke V. The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis. Behav Brain Res 2011, 218:57-63.
48. Kulesskaya N., Voikar V. Assessment of mouse anxiety-like behavior in the light-dark box and open-field arena: role of equipment and procedure. Physiol Behav 2014, 133:30-38.
49. Lupien S.J., McEwen B.S., Gunnar M.R., Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 2009, 10:434-445.
50. Maes M., Yirmyia R., Noraberg J., Brene S., Hibbeln J., Perini G., Kubera M., Bob P., Lerer B., Maj M. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 2009, 24:27-53.
51. McEwen B.S. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism 2005, 54:20-23.
52. Moncada S., Erusalimsky J.D. Does nitric oxide modulate mitochondrial energy generation and apoptosis?. Nat Rev Mol Cell Biol 2002, 3:214-220.
53. Montezuma K., Biojone C., Lisboa S.F., Cunha F.Q., Guimaraes F.S., Joca S.R.L. Inhibition of iNOS induces antidepressant-like effects in mice. Pharmacological and genetic evidence. Neuropharmacology 2012, 62:485-491.
54. Mutlu O., Ulak G., Laugeray A., Belzung C. Effects of neuronal and inducible NOS inhibitor 1-[2-(trifluoromethyl) phenyl] imidazole (TRIM) in unpredictable chronic mild stress procedure in mice. Pharmacol Biochem Behav 2009, 92:82-87.
55. Nahman S., Belmaker R., Azab A.N. Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells. Innate Immun 2012, 18:447-458.
56. Nassar A., Azab A.N. Effects of lithium on inflammation. ACS Chem Neurosci 2014, 5:451-458.
57. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nat Neurosci 2010, 13:1161-1169.
58. Olivenza R., Moro M.A., Lizasoain I., Lorenzo P., Fernández A.P., Rodrigo J., Boscá L., Leza J.C. Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex. J Neurochem 2000, 74:785-791.
59. Pariante C.M., Lightman S.L. The HPA axis in major depression: classical theories and new developments. Trends Neurosci 2008, 31:464-468.
60. Peng Y.-L., Liu Y.-N., Liu L., Wang X., Jiang C.-L., Wang Y.-X. Inducible nitric oxide synthase is involved in the modulation of depressive behaviors induced by unpredictable chronic mild stress. J Neuroinflammation 2012, 9:75.
61. Picard M., Juster R.-P., McEwen B.S. Mitochondrial allostatic load puts the 'gluc' back in glucocorticoids. Nat Rev Endocrinol 2014, 10:303-310.
62. Pisu M.G., Dore R., Mostallino M.C., Loi M., Pibiri F., Mameli R., Cadeddu R., Secci P.P., Serra M. Down-regulation of hippocampal BDNF and Arc associated with improvement in aversive spatial memory performance in socially isolated rats. Behav Brain Res 2011, 222:73-80.
63. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice. a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977, 229:327-336.
64. Rettori V., Fernandez-Solari J., Mohn C., Zubilete M.A.Z., De La Cal C., Prestifilippo J.P., De Laurentiis A. Nitric oxide at the crossroad of immunoneuroendocrine interactions. Ann N Y Acad Sci 2009, 1153:35-47.
65. Réus G.Z., Fries G.R., Stertz L., Badawy M., Passos I.C., Barichello T., Kapczinski F., Quevedo J. The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neuroscience 2015, 300:141-154.
66. Romeo R.D. Adolescence. a central event in shaping stress reactivity. Dev Psychobiol 2010, 52:244-253.
67. Sakuma I., Togashi H., Yoshioka M., Saito H., Yanagida M., Tamura M., Kobayashi T., Yasuda H., Gross S.S., Levi R. NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone?. Circ Res 1992, 70:607-611.
68. Sandi C., Haller J. Stress and the social brain: behavioural effects and neurobiological mechanisms. Nat Rev Neurosci 2015, 16:290-304.
69. Serra M., Pisu M.G., Floris I., Biggio G. Social isolation-induced changes in the hypothalamic-pituitary-adrenal axis in the rat. Stress 2005, 8:259-264.
70. Serra M., Sanna E., Mostallino M.C., Biggio G. Social isolation stress and neuroactive steroids. Eur Neuropsychopharmacol 2007, 17:1-11.
71. Silachev D.N., Gulyaev M.V., Zorova L.D., Khailova L.S., Gubsky L.V., Pirogov Y.A., Plotnikov E.Y., Sukhikh G.T., Zorov D.B. Magnetic resonance spectroscopy of the ischemic brain under lithium treatment. Link to mitochondrial disorders under stroke. Chem Biol Interact 2015, 237:175-182.
72. Sisk C.L., Foster D.L. The neural basis of puberty and adolescence. Nat Neurosci 2004, 7:1040-1047.
73. Tomaz V.S., Cordeiro R.C., Costa A.M.N., de Lucena D.F., Nobre Júnior H.V., de Sousa F.C.F., Vasconcelos S.M.M., Vale M.L., Quevedo J., Macêdo D. Antidepressant-like effect of nitric oxide synthase inhibitors and sildenafil against lipopolysaccharide-induced depressive-like behavior in mice. Neuroscience 2014, 268:236-246.
74. Tsigos C., Chrousos G.P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002, 53:865-871.
75. Tsuji M., Higuchi Y., Shiraishi K., Kume T., Akaike A., Hattori H. Protective effect of aminoguanidine on hypoxic-ischemic brain damage and temporal profile of brain nitric oxide in neonatal rat. Pediatr Res 2000, 47:79-83.
76. Valvassori S.S., Tonin P.T., Varela R.B., Carvalho A.F., Mariot E., Amboni R.T., Bianchini G., Andersen M.L., Quevedo J. Lithium modulates the production of peripheral and cerebral cytokines in an animal model of mania induced by dextroamphetamine. Bipolar Disord 2015, 17:507-517.
77. Veenema A.H., Meijer O.C., de Kloet E.R., Koolhaas J.M., Bohus B.G. Differences in basal and stress-induced HPA regulation of wild house mice selected for high and low aggression. Horm Behav 2003, 43:197-204.
78. Wang D., An S.C., Zhang X. Prevention of chronic stress-induced depression-like behavior by inducible nitric oxide inhibitor. Neurosci Lett 2008, 433:59-64.
79. Zlatković J., Todorović N., Bošković M., Pajović S.B., Demajo M., Filipović D. Different susceptibility of prefrontal cortex and hippocampus to oxidative stress following chronic social isolation stress. Mol Cell Biochem 2014, 393:43-57.